Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalDiabetes Care
Issue number22
Pages (from-to)1137-1143
ISSN0149-5992
Publication statusPublished - 1999

ID: 192007